Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry
- PMID: 40175882
- DOI: 10.1093/rheumatology/keaf181
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry
Abstract
Objectives: Proteinuria, amyloidosis and kidney failure are the main long-term renal complications of FMF. This study assesses their risk factors, independent of ethnicity or residence.
Methods: Patients' data were drawn from the International AIDA Network registry for monogenic autoinflammatory diseases.
Results: A total of 598 FMF patients were enrolled, with 80 having proteinuria, 61 amyloidosis and 25 kidney failure. At multivariate regression analysis, proteinuria was associated with out-of-flares thrombocytosis (odds ratio [OR]: 4.78, 95% CI: 1.54-14.8, P = 0.007), increased out-of-flares ESR (OR: 2.7, 95% CI: 1.3-5.6, P = 0.008), homozygous M694V mutation (OR: 2.27, 95% CI: 1.1-4.66, P = 0.025) and heterozygous M694V mutation (OR: 0.29, 95% CI: 0.09-0.86, P = 0.026); amyloidosis was associated with the disease duration (OR: 1.034, 95% CI: 1.004-1.065, P = 0.027), during-flares anaemia (OR: 2.9, 95% CI: 1.18-7.19, P = 0.021), out-of-flares leucocytosis (OR: 7.47, 95% CI: 1.6-34.7, P = 0.01), increased out-of-flares ESR (OR: 3.6, 95% CI: 1.48-8.81, P = 0.005) and heterozygous M694V mutation (OR: 0.18, 95% CI: 0.035-0.9, P = 0.04); kidney failure was associated with the age at diagnosis (OR: 1.04, 95% CI: 1.0003-1.19, P = 0.048), the disease duration in years (OR: 1.07, 95% CI: 1.02-1.12, P = 0.005), attack frequency per year (OR: 1.04, 95% CI: 1.007-1.076, P = 0.019), anaemia out-of-flares (OR: 4.7, 95% CI: 1.004-22.1, P = 0.049) and out-of-flares leucocytosis (OR: 25.8, 95% CI: 2.75-242, P = 0.004). The intraclass correlation coefficient related to ethnicity and country of residence was 6.7% and 6.8% for amyloidosis, respectively, and 0% for proteinuria and kidney failure.
Conclusion: FMF patients with older age at diagnosis, longer disease duration, anaemia, leucocytosis, thrombocytosis, elevated ESR and homozygous M694V mutation are at higher risk of kidney complications.
Keywords: FMF; complications; kidney; outcome; prognosis.
© The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
